荷兰Lareb药物警戒中心1991至2021年草药药品及草药补充剂不良反应报告分析
该研究对1991年至2021年2月荷兰Lareb药物警戒中心收到的789份草药药品和草药补充剂不良反应报告进行了分类分析,涉及823个可疑草药产品,共导致1727例不良反应。约15%的报告涉及严重不良反应,掺假产品具有导致严重不良反应的高风险。草药产品药物警戒对确保其安全使用至关重要。
要点
- 草药药品和补充剂均可引起不良反应,约15%报告为严重不良反应。
- 掺假草药产品导致严重不良反应的风险较高。
- 应加强草药产品的药物警戒以保障安全使用。
核心结论
- 荷兰药物警戒数据库分析显示草药药品和补充剂涉及多种可疑草药成分,报告为了解荷兰使用的草药产品及其相关不良反应提供了信息。
研究设计与样本
- 对1991年至2021年2月提交至Lareb的草药药品和草药补充剂不良反应报告进行分类分析,按注册状态和草药成分分类,采用描述性统计和透视表分析。
主要发现
- 截至2021年2月共收到789份报告,涉及823个可疑草药产品,导致1727例不良反应。
- 823个产品中229个注册为药品,594个作为草药补充剂上市。
- 522份报告涉及单一草药产品,256份涉及复方产品,27份涉及含草药成分的维生素产品,18份涉及产品问题。
- 约15%的报告涉及严重不良反应,掺假产品具有导致严重不良反应的高风险。
临床怎么用
- 临床应关注草药药品和补充剂的不良反应,尤其警惕掺假产品相关的严重不良反应风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm. OBJECTIVE: We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved. METHODS: We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data. RESULTS: Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions. CONCLUSIONS: Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use.
引用
- van Hunsel FPAM, van der Kooi D, van de Koppel S, et al. Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb. Drug Saf. 2022. PMID: 35608783. doi:10.1007/s40264-022-01180-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。